Article
CaCO <sub>3</sub> Nanoparticles Delivering MicroRNA-200c Suppress Oral Squamous Cell Carcinoma
2023-10-05
Abstract excerpt
MicroRNA (miR)-200c suppresses the initiation and progression of oral squamous cell carcinoma (OSCC), the most prevalent head and neck cancer with high recurrence, metastasis, and mortality rates. However, miR-200c -based gene therapy to inhibit OSCC growth and metastasis has yet to be reported. To develop an miR-based gene therapy to improve the outcomes of OSCC treatment, this study investigates the feasibility...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1cd32fef-caf0-5294-afe1-96b39a7f05c9
- DOI
- 10.1101/2023.10.05.561110
